Business

Innovotech Inc. Announces Intention to Apply for Trading on the OTCQB Venture Market

(TheNewswire)   January 26, 2026 – TheNewswire - Edmonton, Alberta –...

articleInnovotech Inc.January 26, 20264/company/innovotech-inc/news/innovotech-inc-announces-intention-to-apply-for-trading-on-the-otcqb-venture-market
Innovotech Inc. Announces Intention to Apply for Trading on the OTCQB Venture Market

About this update from Innovotech Inc.

[{"type":"text","content":"Innovotech Inc. Announces Intention to Apply for Trading on the OTCQB Venture Market\n(TheNewswire)\n\n\n\n \n\n\nJanuary 26, 2026 – TheNewswire - Edmonton,\nAlberta – Innovotech Inc. (TSXV: IOT, “Innovotech”, or the “Company”) announces\nits intention to obtain a stock quotation in the\nUnited States and a trading symbol on the OTC Markets (“OTCQB”),\nan over-the-counter venture market.  A quotation on the OTCQB will\nenhance the Company’s visibility to the investment community with\nthe goal of making the Company more accessible to retail and\ninstitutional investors in the United States and to increase the\nliquidity of the Company.\n\n\n \n\n\nThe OTCQB quotation operates in parallel with the\nCompany’s primary Canadian listing.  The OTCQB quotation is\nexpected to impose no additional material compliance or reporting\nrequirements. As a foreign private issuer, Innovotech will continue to\nmeet its existing primary market disclosure obligations on SEDAR+,\nwhich satisfy OTC market requirements under established foreign issuer\nexemptions. To be considered for admission to the OTCQB, companies\nmust meet certain financial standards, be current in their reporting\nobligations, and undergo an annual verification and management\ncertification process.\n\n\n \n\n\nIn conjunction with the listing, the Company will also\napply for eligibility with the Depository Trust Company\n(\"DTC\"), enabling simplified\nelectronic clearing and settlement of its common shares for U.S.\ninvestors. \n\n\n \n\n\nAbout Innovotech: \n\n\nInnovotech Inc. is a Canadian boutique contract\nresearch organization specializing in advanced laboratory services and\ncommercializing proprietary technologies. A leader in biofilm science,\nthe company provides expertise in antimicrobial testing,\npharmaceutical analysis, and industrial laboratory solutions,\nsupported by innovative methodologies and products including\nits widely-used MBEC\nAssay® kit for high-throughput\nantimicrobial and antibiotic testing. Innovotech\nserves clients across multiple sectors, delivering customized research\nand testing services designed to meet rigorous regulatory and\nscientific standards such as those of the U.S. Food and Drug\nAdministration and Health Canada through...

More updates from Innovotech Inc.